Droplet microfluidics-based detection of rare antibiotic-resistant subpopulations in <i>Escherichia coli</i> from bloodstream infections.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 40614180.
- Also identified by DOI 10.1126/sciadv.adv4558 and PMC identifier 12227044.
- Licence recorded as CC BY-NC.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Population heterogeneity in bacterial phenotypes, such as antibiotic resistance, is increasingly recognized as a medical concern. Heteroresistance occurs when a predominantly susceptible bacterial population harbors a rare resistant subpopulation. During antibiotic exposure, these resistant bacteria can be selected and lead to treatment failure. Standard antibiotic susceptibility testing methods often fail to reliably detect these subpopulations due to their low frequency, highlighting the need for improved diagnostic approaches. Here, we present a droplet microfluidics method where bacteria are encapsulated in droplets containing growth medium and antibiotics. The growth of rare resistant cells is detected by observing droplet shrinkage under microscopy. We validated this method for three clinically important antibiotics in <i>Escherichia coli</i> isolates obtained from bloodstream infections and showed that it can detect resistant subpopulations as infrequent as 10<sup>-6</sup> using only 200 to 300 droplets. In addition, we designed a multiplex microfluidic chip to increase the throughput of the assay.
Medical subject headings
- Escherichia coli
- Anti-Bacterial Agents
- Microfluidics
- Drug Resistance, Bacterial
- Escherichia coli Infections
- Microfluidic Analytical Techniques
- Bacteremia